Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis
AimAdvanced glycation end products (AGEs) are pivotal mediators in diabetic kidney disease (DKD). However, their prognostic utility remains underexplored. This study introduced corrected lgAGEs [novel biomarker derived by adjusting logarithmically transformed AGEs (lgAGEs) levels based on serum albu...
Saved in:
Main Authors: | Ze-Hou Wang, Zong-Jin Zhang, Yue-Fen Wang, Jin Xie, Yi-Min Li, Cun Shen, Yuan Meng, Wen-Jing Zhao, Lu-Ying Sun, Wei Jing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2025.1541198/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Facial assessment methods for inhibiting glycation and aging effects and the correlation between glycation and aging parameters
by: Qin Zhang, et al.
Published: (2025-01-01) -
Association of Albumin‐To‐Creatinine Ratio With Diabetic Retinopathy Among US Adults (NHANES 2009–2016)
by: Han Dai, et al.
Published: (2025-01-01) -
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study
by: Mohsen Shaygan Tabar, et al.
Published: (2025-02-01) -
Clinical importance of borderline proteinuria in nonazotemic cats and evaluation of other risk factors for the development of chronic kidney disease
by: Femke Mortier, et al.
Published: (2025-01-01) -
The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
by: Nada H. Aljarba, et al.
Published: (2025-03-01)